We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > FDA nod

News List

Pfizer, Astellas' Xtandi Gets FDA nod biospectrumasia
December 18, 2019
For the treatment of patients with metastatic castration-sensitive prostate cancer
Chasing Pfizer and J&J, Bayer’s Nubeqa nabs fast FDA nod in prostate cancer biospectrumasia
August 01, 2019
Pfizer and Astellas’ Xtandi and Johnson & Johnson’s Erleada may have big head starts in the prostate cancer market, but Bayer and partner Orion have a new entry—and they're looking to carve out a share.
Merck's Keytruda, up for new FDA nod, spurs lengthy responses in small cell lung cancer fiercepharma
April 02, 2019
Merck & Co. is awaiting an FDA decision for Keytruda in previously treated small cell lung cancer, and it has new numbers to boost its case.
Sanofi scores FDA nod for $270K nanobody drug Cablivi, its first from the Ablynx deal fiercepharma
February 24, 2019
Sanofi scooped up nanobody biotech Ablynx last year in a $4.5 billion deal—and now, the buyout may be starting to pay off. Cablivi, an Ablynx nanobody for a rare blood-clotting disorder, has snagged its FDA green light.